Antitrust Radar
Back to enforcement atlas
Organization JSONRecords CSV
Exact official-record label

Caremark Rx, LLC

Pharmacy benefit manager named in FTC study and administrative complaint records.

Exact source label, not a standalone legal-entity, ownership, liability, or market-power determination.

Official record topology2024-2026 / 1 public body / 3 unavailable
Official labelCaremark Rx, LLC
RemedyJul 14, 2026

FTC announces proposed consent agreement with Caremark

Federal Trade Commission

Named role
Remedy subject
HHI coverage
0 paired / 1
Policy organizationCaremark Rx, LLCOfficial label / 3 records / 2024-2026

  • Record identityExact source labelNot legal-entity resolution
  • Official coverage3 dated records2024-2026
  • Market scope1 contextLinked by the official record
  • Permitted useRecord tracingNot a liability finding

Official record chronology

Why this exact label appears

3 records / 3 sources

Jul 14, 2026

Remedy

Docket Docket No. 9437

Federal Trade Commission

FTC announces proposed consent agreement with Caremark

The FTC announced a proposed consent agreement with Caremark and Zinc Health Services addressing formulary design, point-of-sale rebates, fee structures, plan-sponsor transparency, community-pharmacy reimbursement, and access to pharmacy hub services.

Named as Remedy subject

The FTC settlement announcement identifies Caremark among the entities subject to the proposed consent agreement.

PBMs
Economic coverage0 paired / 1 windows
Official source Record dossier Event JSON

Descriptive economic context

Public HHI evidence around each record

Each row searches the linked market profile for strict pre-event, same-year, and strict post-event observations. Missing anchors remain visible.

0Paired
0One-sided
3Unavailable
HHI unavailable2026-07-14
PBMs

FTC announces proposed consent agreement with Caremark

Strict pre
Unavailable
No earlier HHI
Event year
Unavailable
No same-year HHI
Strict post
Unavailable
No later HHI
Pre-post change
Not available
Pair not available
HHI unavailable2024-09-20
PBMs

FTC files administrative complaint against the three largest PBMs

Strict pre
Unavailable
No earlier HHI
Event year
Unavailable
No same-year HHI
Strict post
Unavailable
No later HHI
Pre-post change
Not available
Pair not available
HHI unavailable2024-07-09
PBMs

FTC releases interim staff report on prescription drug middlemen

Strict pre
Unavailable
No earlier HHI
Event year
Unavailable
No same-year HHI
Strict post
Unavailable
No later HHI
Pre-post change
Not available
Pair not available

Before/after HHI differences are descriptive comparisons between discrete public releases. They do not estimate the causal effect of the policy event.

Bounded market context

Markets linked by the cited records

1 profile handoffs

United States / Health care

PBMs

3 named records / 0 paired HHI windows

Remedy subjectRespondentReport subject
Open market profile

A market link records the scope named by the official event. It does not establish that every named organization participates throughout that market or define a relevant antitrust market for a different matter.

Source custody

Official records behind the dossier

3 public sources

Reproducible record packet

Reuse the exact organization dossier

Filtered index and relationship routes preserve the organization slug, exact role, event ID, market context, source URL, and inference guardrails.

Organization ID
pent-caremark-rx
Profile slug
caremark-rx-llc
Named edges
3
License
CC BY 4.0

Official-record interpretation boundary

These dossiers compile exact organization labels from official public records. They do not resolve corporate identity, ownership, control, affiliate status, liability, or market power beyond what the cited record expressly states.

A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.

Evidence standard